1)一般社団法人日本環境感染学会:医療機関における新型コロナウイルス感染症への対応ガイド第3版,2020年5月8日 http://www.kankyokansen.org/modules/news/index.php?content_id=355(2020年10月閲覧)
2)一般社団法人日本感染症学会:一般社団法人日本感染症学会提言 今冬のインフルエンザとCOVID-19に備えて,2020年8月3日 http://www.kansensho.or.jp/modules/guidelines/index.php?content_id=41(2020年10月閲覧)
3)病原体検査の指針検討委員会:新型コロナウイルス感染症(COVID-19)病原体検査の指針第1版,2020 https://www.mhlw.go.jp/content/000678571.pdf(2020年10月閲覧)
4)Uyeki TM, et al:Clinical Practice Guidelines by the infectious diseases society of America ;2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenzaa. Clin Infect Dis 68:e1-e47, 2019
5)Ding Q, et al:The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China. J Med Virol 92:1549-1555, 2020
6)Kim D, et al:Rates of co-infection between SARS-CoV-2 and other respiratory pathogens. JAMA 323:2085-2086, 2020
7)Metlay JP, et al:Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med 200:e45-e67, 2019
8)Vaughn VM, et al:Empiric antibacterial therapy and community-onset bacterial co-infection in patients hospitalized with COVID-19 ;A multi-hospital cohort study(online ahead of print, 2020 Aug 21). Clin Infect Dis, 2020
9)Sieswerda E, et al:Recommendations for antibacterial therapy in adults with COVID-19;An evidence based guideline(online ahead of print, 2020 Oct 1). Clin Microbiol Infect, 2020
10)黒田浩一:亀田流 市中肺炎診療レクチャー—感染症医と呼吸器内科医の視点から,中外医学社,2019